Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: Report of two cases

Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) is a new, mostly supportive approach to help patients with advanced peritoneal metastasis to increase the lifespan. It carries occupational hazards to health-care workers and especially anaesthesiologist during the procedure. The aerosolised chemotherapy can also cause chemical peritonitis and organ dysfunction in the perioperative period. In this case report, we present the report of two cases and discuss the perioperative concerns and management related to PIPAC.

• Publication year

  2018

• Venue

  Indian Journal of Anaesthesia

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/ija.IJA_623_17PMID 29643558PMCID 5881326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minimizing Occupational Exposure to Antineoplastic Agents

  2016cited by this paper
• Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis

  2016cited by this paper
• Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2016cited by this paper
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis

  2015cited by this paper
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects

  2013cited by this paper
• Systematic review of intraperitoneal chemotherapy for gastric cancer

  2011cited by this paper
• Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity

  2011cited by this paper
• Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.

  2011cited by this paper
• Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence

  2010cited by this paper

• Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework

  2022cites this paper
• Coronavirus Disease (COVID-19) and Peritoneal Malignancies

  2021cites this paper
• Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework

  2020cites this paper
• Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.

  2020cites this paper
• Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

  2019cites this paper
• Perioperative management of cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) for pseudomyxoma peritonei

  2019cites this paper
• Oxaliplatin

  2018cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit!

  2018cites this paper